110 related articles for article (PubMed ID: 19683395)
1. Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat.
Norcini M; Vivoli E; Galeotti N; Bianchi E; Bartolini A; Ghelardini C
Pain; 2009 Nov; 146(1-2):141-7. PubMed ID: 19683395
[TBL] [Abstract][Full Text] [Related]
2. Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy.
Joseph EK; Levine JD
Neuroscience; 2003; 119(3):831-8. PubMed ID: 12809704
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
4. Altered Expression of Cytoskeletal and Axonal Proteins in Oxaliplatin-Induced Neuropathy.
Sanna MD; Ghelardini C; Galeotti N
Pharmacology; 2016; 97(3-4):146-50. PubMed ID: 26821153
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.
Joseph EK; Levine JD
J Pain; 2009 May; 10(5):534-41. PubMed ID: 19231296
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia.
Sakurai M; Egashira N; Kawashiri T; Yano T; Ikesue H; Oishi R
Pain; 2009 Dec; 147(1-3):165-74. PubMed ID: 19782472
[TBL] [Abstract][Full Text] [Related]
7. Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat.
Dina OA; Chen X; Reichling D; Levine JD
Neuroscience; 2001; 108(3):507-15. PubMed ID: 11738263
[TBL] [Abstract][Full Text] [Related]
8. H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway.
Galeotti N; Malmberg-Aiello P; Bartolini A; Schunack W; Ghelardini C
Neuropharmacology; 2004 Aug; 47(2):295-303. PubMed ID: 15223308
[TBL] [Abstract][Full Text] [Related]
9. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
[TBL] [Abstract][Full Text] [Related]
10. PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy.
Sanna MD; Quattrone A; Ghelardini C; Galeotti N
Pharmacol Res; 2014 Mar; 81():44-53. PubMed ID: 24565699
[TBL] [Abstract][Full Text] [Related]
11. Mechanical hyperalgesia induced by endothelin-1 in rats is mediated via phospholipase C, protein kinase C, and MAP kinases.
Motta EM; Calixto JB; Rae GA
Exp Biol Med (Maywood); 2006 Jun; 231(6):1141-5. PubMed ID: 16741065
[TBL] [Abstract][Full Text] [Related]
12. Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model.
Kawashiri T; Egashira N; Watanabe H; Ikegami Y; Hirakawa S; Mihara Y; Yano T; Ikesue H; Oishi R
Eur J Pain; 2011 Apr; 15(4):344-50. PubMed ID: 20829082
[TBL] [Abstract][Full Text] [Related]
13. Glial role in oxaliplatin-induced neuropathic pain.
Di Cesare Mannelli L; Pacini A; Micheli L; Tani A; Zanardelli M; Ghelardini C
Exp Neurol; 2014 Nov; 261():22-33. PubMed ID: 24967684
[TBL] [Abstract][Full Text] [Related]
14. The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy.
Wozniak KM; Wu Y; Vornov JJ; Lapidus R; Rais R; Rojas C; Tsukamoto T; Slusher BS
J Pharmacol Exp Ther; 2012 Dec; 343(3):746-54. PubMed ID: 22988061
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.
Ling B; Coudoré-Civiale MA; Balayssac D; Eschalier A; Coudoré F; Authier N
Toxicology; 2007 May; 234(3):176-84. PubMed ID: 17418472
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat.
Joseph EK; Chen X; Khasar SG; Levine JD
Pain; 2004 Jan; 107(1-2):147-58. PubMed ID: 14715401
[TBL] [Abstract][Full Text] [Related]
17. Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
Fujita S; Ushio S; Ozawa N; Masuguchi K; Kawashiri T; Oishi R; Egashira N
PLoS One; 2015; 10(11):e0141921. PubMed ID: 26536615
[TBL] [Abstract][Full Text] [Related]
18. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.
Renn CL; Carozzi VA; Rhee P; Gallop D; Dorsey SG; Cavaletti G
Mol Pain; 2011 Apr; 7():29. PubMed ID: 21521528
[TBL] [Abstract][Full Text] [Related]
19. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.
Toyama S; Shimoyama N; Ishida Y; Koyasu T; Szeto HH; Shimoyama M
Anesthesiology; 2014 Feb; 120(2):459-73. PubMed ID: 24064792
[TBL] [Abstract][Full Text] [Related]
20. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
Xiao WH; Zheng H; Bennett GJ
Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
